(Reuters) - Medical device maker Boston Scientific Corp said it would buy privately held heart device maker BridgePoint Medical Inc to gain access to its product that restores blood flow in blocked coronary arteries. Minneapolis, Minnesota-based BridgePoint's catheter-based system is approved by the U.S. Food and Drug Administration and European health regulators to treat chronically occluded coronary arteries -- which are blocked typically for 3 months or longer -- that prevent blood circulation to critical areas of the heart. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment